The objective of the proposed research is to determine the extent to which modifications of the guanine nucleotide-binding proteins G?s? and G?i? participate in the regulation of adenylate cyclase coincident with malignant transformation. Transformation of various cells by Rous and Kirsten sarcoma viruses will be empoloyed as models for investigation. An initial aim of the proposed research is the analysis of G?s? and G?i? function in relation to transformation. The ability of G?s? and G?i? to mediate activation and inhibition of adenylate cyclase in native plasma membranes and in reconstituted systems will be investigated. A subsequent aim is the development of antibodies specific for subunits of G?s? and G?i?. Antibodies will be elicited by immunization with conjugated synthetic peptides that correspond to hydrophilic regions of these proteins. Serum titer and specificity will be monitored by solid-phase techniques and procedures of immunoprecipitation.
The third aim i s the assessment of regulatory events that may impinge upon G?s? and G?i? in relation to transformation. Events to be investigated include alterations in level of G?s? and G?i?, alterations in relative levels of isozymic forms of these proteins, post-translational modification, and physical interactions with other proteins.
This aim will be achieved by employment of radiolabel and immunological procedures. Alterations in basal activities of adenylate cyclase, and in the responsiveness of this enzyme to extracellular agents, have been suggested as participating in transformation, metastasis, differentiation, and progression of the cell cycle. The ultimate objective of the proposed research is to contribute to the understanding of the relationship between these alterations and the general phenomenon of cell proliferation. (N)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039712-03
Application #
3179068
Study Section
Biochemistry Study Section (BIO)
Project Start
1985-04-01
Project End
1988-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Thomas, P A; Kirschmann, D A; Cerhan, J R et al. (1999) Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 5:2698-703
Yang, L; Camoratto, A M; Baffy, G et al. (1993) Epidermal growth factor-mediated signaling of G(i)-protein to activation of phospholipases in rat-cultured hepatocytes. J Biol Chem 268:3739-46
Lounsbury, K M; Schlegel, B; Poncz, M et al. (1993) Analysis of Gz alpha by site-directed mutagenesis. Sites and specificity of protein kinase C-dependent phosphorylation. J Biol Chem 268:3494-8
Brass, L F; Hoxie, J A; Kieber-Emmons, T et al. (1993) Agonist receptors and G proteins as mediators of platelet activation. Adv Exp Med Biol 344:17-36
Morris, S A; Horn, E M; Hawley, T et al. (1991) The influence of detergents on the availability of pertussis toxin substrates. Arch Biochem Biophys 290:86-92
Manning, D R; Brass, L F (1991) The role of GTP-binding proteins in platelet activation. Thromb Haemost 66:393-9
Matesic, D F; Manning, D R; Luthin, G R (1991) Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins. Mol Pharmacol 40:347-53
Law, S F; Manning, D; Reisine, T (1991) Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J Biol Chem 266:17885-97
Gagnon, A W; Manning, D R; Catani, L et al. (1991) Identification of Gz alpha as a pertussis toxin-insensitive G protein in human platelets and megakaryocytes. Blood 78:1247-53
Lounsbury, K M; Casey, P J; Brass, L F et al. (1991) Phosphorylation of Gz in human platelets. Selectivity and site of modification. J Biol Chem 266:22051-6

Showing the most recent 10 out of 20 publications